Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020

Prevalence of SARS-CoV-2–Specific Antibodies, Japan, June 2020

We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating s...

Full description

Bibliographic Details
Main Authors: Takashi Yoshiyama, Yasuki Saito, Kunitsugu Masuda, Yoshiko Nakanishi, Yasutoshi Kido, Kazuhiro Uchimura, Satoshi Mitarai, Tadaki Suzuki, Yu Nakagama, Hiroshi Kubota, Maki Satomi, Sana Uchikoba, Makoto Ohnishi, Takaji Wakita, Seiya Kato, Katsunobu Kato
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2021-02-01
Series:Emerging Infectious Diseases
Subjects:
seroprevalence
antibodies
SARS-CoV-2
COVID-19
diagnostics
immunology
Online Access:https://wwwnc.cdc.gov/eid/article/27/2/20-4088_article

Internet

https://wwwnc.cdc.gov/eid/article/27/2/20-4088_article

Similar Items